The revolutionary potential of mRNA as a platform for biopharma
Birgit Rogell, Roche CustomBiotech EMEA/LATAM
– Self-testing experience as a strategy to expand the HIV diagnostic, Mariana Villares, DST-AIDS*
– Regulatory framework for new IVD technologies, Marcella Abreu, Anvisa
Chair: Rosane Cuber, Bio-Manguinhos*
IVD-02. New approaches for recombinant protein VP1-2A of HAV production and characterization based on liquid microarray assay: application for developing a point-of care diagnostic test
Michel Vergne Felix Sucupira, Bio-Manguinhos
– The use of large-scale, rapid whole-genome sequencing of SARS-CoV-2 to understand viral transmission and evolution, Lorenzo Subissi, OMS*
– Pandemic of SARS- CoV- 2 in Brazil: evolution and emergence of variants of concern, Marilda Siqueira, Fiocruz*
Chair: Marco Krieger, Fiocruz*
IVD-01. Development and Validation of Reverse Transcription Loop- Mediated Isothermal Amplification (RT-LAMP) for Rapid Detection of SARS-CoV-2 in Human Samples
Bárbara Nazly Rodrigues Santos, Fiocruz
– Rebecca Farkas, CEPI*
– David Kaslow, PATH*
– Peter Dull, B&MGF
Chair: Sotiris Missailidis, Bio-Manguinhos*
– Daniel Pacheco Lacerda, Unisinos*
– Maria Cristina de Cunto Brandileone, Adolfo Lutz Institute*
– Maria Notomi Sato, USP*
– Marco Antonio Stephano, USP*
– Paulo Lee Ho, Butantan Institute*
– Mauricio Zuma, Bio-Manguinhos*
Event close-up remarks
Akira Homma, Bio-Manguinhos